Nel ASA's Liquidity Lifeline Faces Revenue Reality Check

Nel enters pivotal fortnight with strong cash but faces core challenge of converting record orders into revenue. Q1 report on April 22 is key test amid strategic shifts and new tech launch.

With a cash position of approximately NOK 1.6 billion, Norwegian electrolyser manufacturer Nel ASA enters a pivotal fortnight. The company’s substantial liquidity provides a buffer, but it cannot solve the core challenge now squarely in focus: converting a surge of new orders into tangible revenue. All eyes are on the first-quarter report due April 22, which will test whether last year’s landmark contracts are finally translating onto the income statement.

The final quarter of 2025 presented a stark dichotomy for Nel. While total revenue for the year fell by 31%, the company’s order intake in Q4 alone skyrocketed by 364% to NOK 686 million. This dramatic spike was fueled by the largest single order to date for its PEM electrolyser division. Despite this promising pipeline, the company posted a net loss of NOK 870 million for 2025, significantly impacted by a non-cash impairment charge of NOK 799 million.

Recent corporate governance moves underscore a period of strategic realignment. At its digital Annual General Meeting on April 10, shareholders approved a revised executive compensation framework. The company is replacing its previous stock option plan, which contained no performance conditions, with a new Performance Share Unit program. This shift directly ties management rewards to measurable corporate goals, a change long advocated by institutional investors.

A key vote at that same meeting saw the re-election of Gyuyeon Kang to the board. Kang is an Executive Vice President at Samsung E&A, which solidified its position as Nel’s largest single shareholder in March 2025 by acquiring a 9.1% stake for approximately $33 million. His continued board presence formally cements Samsung’s role as a preferred global hydrogen partner and signals a commitment to long-term collaboration.

Market analysts remain cautious, reflecting the uncertainty surrounding order conversion. In March 2026, Berenberg analyst James Carmichael reaffirmed his ‘Hold’ rating on the stock but cut his price target from NOK 2.60 to NOK 2.30. He cited the difficult-to-predict timing of turning orders into revenue and the unproven nature of Nel’s new platform model. Citi followed suit, reducing its target from NOK 2.70 to NOK 2.40 while also maintaining a ‘Hold’ stance.

Beyond immediate financials, Nel is banking on a technological leap. The commercial launch of its new Next Generation Pressurized Alkaline electrolyser system is slated for the first half of 2026. The company claims the platform will be significantly more compact and up to 60% cheaper to manufacture than current models. Large-scale deliveries are planned for 2027. To support this rollout, the European Union’s Innovation Fund has earmarked up to EUR 135 million in grants, covering about 60% of eligible costs for a production capacity of up to 1 GW at the Herøya site. An initial tranche of over EUR 10 million will be triggered by the final investment decision.

The upcoming quarterly report will deliver a crucial data point. It must demonstrate measurable progress in closing the gap between the impressive order book and actual revenue generation. For investors, the thesis for 2026 hinges on Nel proving its operational execution can match its strategic partnerships and technological ambition.